# FDA 483 - Revlon Group Holdings, LLC - January 12, 2024

Source: https://www.globalkeysolutions.net/records/483/revlon-group-holdings-llc/7f81f7b2-8bf2-4605-b54a-901ecf8e20c3

> FDA 483 for Revlon Group Holdings, LLC on January 12, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Revlon Group Holdings, LLC
- Inspection Date: 2024-01-12
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: Revlon Group Holdings, LLC in Oxford, NC, received a Form 483 following an FDA inspection from January 8-12, 2024. The inspection revealed significant deficiencies in equipment cleaning and sanitation, laboratory controls for water testing, and line clearance procedures, indicating potential cross-contamination and product quality issues in their OTC drug manufacturing.

## Related Officers

- [Program Coordinator](https://www.globalkeysolutions.net/people/martrice-a-packer/e9d89635-6323-4dc7-9222-c44cedcf46c2)

Company: https://www.globalkeysolutions.net/companies/revlon-group-holdings-llc/8adabd5e-2a5c-4cfe-a5b2-3a4717b2b654

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7